Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

paclitaxel poliglumex

The agent paclitaxel linked to a biodegradable, water-soluble polyglutamate polymer with antineoplastic properties. The polyglutamate residue increases the water solubility of paclitaxel and allows delivery of higher doses than those achievable with paclitaxel alone. Paclitaxel promotes microtubule assembly and prevents microtubule depolymerization, thus interfering with normal mitosis.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	paclitaxel-polyglutamate polymer Poly-L-Glutamic acid-Paclitaxel Conjugate polyglutamate paclitaxel polyglutamic acid paclitaxel
US brand name:	Xyotax
Abbreviation:	PG-TXL
Code name:	CT-2103

paclitaxel poliglumex

Search NCI's Drug Dictionary